SCHEMBL16485334

SCHEMBL16485334

c1ccc(N(c2ccc(-c3cccnc3)cc2)c2cccc(-c3ccc4c5c(cccc35)-c3cc5ccccc5cc3-4)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 9/20 0.43
CYP11B2 P19099 7/20 0.42
CYP19A1 P11511 3/20 0.42
CYP17A1 P05093 1/20 0.42
TNF P01375 1/20 0.39
FYN P06241 1/20 0.38
DHODH Q02127 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
STAT1 P42224 1/20 0.38
CYP2A6 P11509 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.35
USP1 O94782 1/20 0.35
WDR48 Q8TAF3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16485336 0.96 CYP11B1 (0.45) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL16485331 0.93 CYP11B1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL17012216 0.92 CYP11B1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL16484746 0.92 CYP11B1 (0.44) CYP11B1CYP11B2CYP19A1CYP17A1FYN
SCHEMBL16484714 0.92 CYP11B1 (0.44) CYP11B1CYP11B2CYP19A1CYP17A1FYN
SCHEMBL16484067 0.90 CYP11B1 (0.42) CYP11B1CYP11B2CYP19A1CYP17A1FYN
SCHEMBL16485114 0.90 CYP11B1 (0.45) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL16484093 0.89 CYP11B1 (0.41) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL16484087 0.89 CYP11B1 (0.40) CYP11B1CYP11B2CYP19A1CYP17A1TNF
SCHEMBL16485360 0.89 CYP11B1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 US disclosed
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
EP-2907803-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT Toray Industries, Inc. (JP) 2015-08-19 EP disclosed
WO-2014057874-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT 東レ株式会社 (JP) 2014-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE FMNL1, AFF2, LEF1 CYP11B1 4354/4885CYP11B2 3859/4885CYP19A1 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.